The Registry of Toxic Effects of Chemical Substances
Carbamoyl chloride, dimethyl - |
UPDATE: May 2005 | MW: 107.55 | MF: C3H6ClNO |
SYNONYMS:
|
|
|
SKIN AND EYE IRRITATION DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
N/R |
N/R
|
N/R
|
N/R
|
|
MUTATION DATA AND REFERENCES:
SYSTEM TEST
|
ROUTE/ | ORGANISM/ TISSUE
DOSE
|
REFERENCE
|
cytogenetic analysis
|
hamster
ovary
|
33 µL/L
|
PMRSDJ 1,551,1981
|
DNA repair
|
Escherichia coli
|
10 mg/L
|
JJIND8 62,873,1979
|
DNA repair
|
Saccharomyes cerevisiae
|
136 µmol/L
|
CNJGA8 24,771,1982
|
DNA repair
|
Schizosaccharomyces pombe
|
136 µmol/L
|
CNJGA8 24,771,1982
|
unscheduled DNA synthesis
|
human
fibroblast
|
32 µg/L
|
PMRSDJ 1,528,1981
|
host-mediated assay
|
mouse
| Salmonella typhimurium
1 gm/kg
|
JJIND8 62,911,1979
|
mutation in microorganisms
|
Escherichia coli
|
100 µg/plate (+/-enzymatic activation step)
|
ENMUDM 6(Suppl 2),1,1984
|
mutation in microorganisms
|
mouse
lymphocyte
|
187 mg/L (+enzymatic activation step)
|
MUREAV 97,49,1982
|
mutation in microorganisms
|
Salmonella typhimurium
|
33 µg/plate (+enzymatic activation step)
|
ENMUDM 5(Suppl 1),3,1983
|
mutation in microorganisms
|
Salmonella typhimurium
|
300 ng/plate (-enzymatic activation step)
|
ENMUDM 6(Suppl 2),1,1984
|
mutation in microorganisms
|
Saccharomyes cerevisiae
|
89 mg/L (+enzymatic activation step)
|
PMRSDJ 1,414,1981
|
mutation in microorganisms
|
Schizosaccharomyces pombe
|
2 mg/L (+/-enzymatic activation step)
|
PMRSDJ 1,424,1981
|
micronucleus test
|
intraperitoneal | mouse
1,400 µg/kg
|
PMRSDJ 1,698,1981
|
gene conversion and mitotic recombination
|
Saccharomyes cerevisiae
|
2 gm/L
|
PMRSDJ 1,481,1981
|
mutation in mammalian somatic cells
|
mouse
lymphocyte
|
1,200 mg/L
|
PMRSDJ 1,580,1981
|
morphological transform
|
hamster
kidney
|
80 µg/L
|
BJCAAI 37,873,1978
|
morphological transform
|
hamster
embryo
|
100 µg/L
|
IJCNAW 19,642,1977
|
other mutation test systems
|
Escherichia coli
|
540 pmol/tube
|
MUREAV 147,79,1985
|
phage inhibition capacity
|
Escherichia coli
|
500 µL/L
|
PMRSDJ 1,224,1981
|
sister chromatid exchange
|
hamster
ovary
|
100 µmol/L
|
MUREAV 118,103,1983
|
sister chromatid exchange
|
hamster
lung
|
100 µmol/L
|
MUREAV 118,103,1983
|
sex chromosome loss and nondisjunction
|
parenteral | Drosophila melanogaster
10 pph
|
ENMUDM 7,349,1985
|
sex chromosome loss and nondisjunction
|
Saccharomyes cerevisiae
|
100 mg/L
|
PMRSDJ 1,468,1981
|
|
REPRODUCTIVE EFFECTS DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
N/R |
N/R
|
N/R
|
N/R
|
|
TUMORIGENIC DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
inhalation | hamster
lowest published toxic concentration: 1 ppm/6 hour/89 week- intermittent
|
Tumorigenic: Carcinogenic by RTECS criteria | Olfaction: Tumors Nutritional and Gross Metabolic: Weight loss or decreased weight gain
JEPTDQ 4(1),107,1980
|
inhalation | hamster
toxic concentration (other than lowest) : 1 ppm/6 hour/2 year- intermittent
|
Tumorigenic: Equivocal tumorigenic agent by RTECS criteria | Olfaction: Tumors
JEPTDQ 4(1),107,1980
|
inhalation | rat
lowest published toxic concentration: 1 ppm/6 hour/6 week- intermittent
|
Tumorigenic: Carcinogenic by RTECS criteria | Olfaction: Tumors
CALEDQ 33,175,1986
|
inhalation | rat
toxic concentration (other than lowest) : 1 ppm/6 hour/6 week- intermittent
|
Tumorigenic: Equivocal tumorigenic agent by RTECS criteria | Lung, Thorax, or Respiration: Tumors
PAACA3 21,106,1980
|
inhalation | rat
toxic concentration (other than lowest) : 1 ppm
|
Tumorigenic: Equivocal tumorigenic agent by RTECS criteria | Olfaction: Tumors
OHSLAM 6,5,1976
|
intraperitoneal | mouse
lowest published toxic dose: 2,560 mg/kg/64 week- intermittent
|
Tumorigenic: Neoplastic by RTECS criteria | Lung, Thorax, or Respiration: Tumors Tumorigenic: Tumors at site of application
JNCIAM 53,695,1974
|
subcutaneous | mouse
lowest published toxic dose: 894 mg/kg/52 week- intermittent
|
Tumorigenic: Carcinogenic by RTECS criteria | Skin and Appendages: Tumors Tumorigenic: Tumors at site of application
JACTDZ 6(4),479,1987
|
subcutaneous | mouse
toxic dose : 8 gm/kg/40 week- intermittent
|
Tumorigenic: Neoplastic by RTECS criteria | Tumorigenic: Tumors at site of application
JNCIAM 53,695,1974
|
subcutaneous | mouse
toxic dose : 5,200 mg/kg/26 week- intermittent
|
Tumorigenic: Neoplastic by RTECS criteria | Lung, Thorax, or Respiration: Tumors Tumorigenic: Tumors at site of application
JNCIAM 48,1539,1972
|
skin | mouse
lowest published toxic dose: 17,280 mg/kg/72 week- intermittent
|
Tumorigenic: Carcinogenic by RTECS criteria | Skin and Appendages: Tumors Tumorigenic: Tumors at site of application
JACTDZ 6(4),479,1987
|
skin | mouse
toxic dose : 13 gm/kg/55 week- intermittent
|
Tumorigenic: Neoplastic by RTECS criteria | Lung, Thorax, or Respiration: Tumors Skin and Appendages: Tumors
JNCIAM 48,1539,1972
|
skin | mouse
toxic dose : 13 gm/kg/55 week- intermittent
|
Tumorigenic: Neoplastic by RTECS criteria | Skin and Appendages: Tumors Tumorigenic: Tumors at site of application
JNCIAM 53,695,1974
|
|
ACUTE TOXICITY DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
inhalation | mouse
lowest published lethal concentration: 1,000 mg/m3/10 minute
|
N/R
|
NDRC** NDCrc-132,OCT1942
|
inhalation | rat
lethal concentration (50 percent kill): 180 ppm/6 hour
|
N/R
|
JEPTDQ 4(1),107,1980
|
intraperitoneal | mouse
lethal dose (50 percent kill): 300 mg/kg
|
Behavioral: Somnolence (general depressed activity)
|
ZAARAM 24,71,1974
|
oral | rat
lethal dose (50 percent kill): 1 gm/kg
|
Behavioral: Somnolence (general depressed activity)
|
ZAARAM 24,71,1974
|
|
OTHER MULTIPLE DOSE DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
N/R |
N/R
|
N/R
|
N/R
|
|
REVIEWS:
ORGANIZATION
|
STANDARD
|
|
REFERENCE
American Conference of Governmental Industrial Hygienists (ACGIH) Threshold Limit Value
|
time-weighted average L
|
DTLVS* TLV/BEI,2003
|
American Conference of Governmental Industrial Hygienists (ACGIH) Threshold Limit Value
|
Suspected Human Carcinogen
|
DTLVS* TLV/BEI,2003
|
International Agency for Research on Cancer (IARC) Cancer Review
|
Animal Sufficient Evidence
|
IMEMDT 12,77,1976
|
International Agency for Research on Cancer (IARC) Cancer Review
|
Animal Sufficient Evidence
|
IMEMDT 71,531,1999
|
International Agency for Research on Cancer (IARC) Cancer Review
|
Human Inadequate Evidence
|
IMEMDT 12,77,1976
|
International Agency for Research on Cancer (IARC) Cancer Review
|
Human Inadequate Evidence
|
IMEMDT 71,531,1999
|
International Agency for Research on Cancer (IARC) Cancer Review
|
Group 2A
|
IMEMDT 71,531,1999
|
|
STANDARDS AND REGULATIONS:
ORGANIZATION
|
STANDARD
|
|
REFERENCE
Occupational Exposure Limit - AUSTRALIA
|
Carcinogen, JAN1993
|
Occupational Exposure Limit - AUSTRIA
|
Carcinogen, JAN1999
|
Occupational Exposure Limit - BELGIUM
|
Carcinogen, JAN1993
|
Occupational Exposure Limit - FINLAND
|
Carcinogen, JAN1999
|
Occupational Exposure Limit - GERMANY
|
Carcinogen, JAN1999
|
Occupational Exposure Limit - SWITZERLAND
|
Carcinogen, JAN1999
|
Occupational Exposure Limit - UNITED KINGDOM
|
Carcinogen, SEP2000
|
Occupational Exposure Limit IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA
|
American Conference of Governmental Industrial Hygienists (ACGIH) Threshold Limit Value; | Suspected Human Carcinogen
Occupational Exposure Limit IN NEW ZEALAND, SINGAPORE, VIETNAM
|
American Conference of Governmental Industrial Hygienists (ACGIH) Threshold Limit Value |
Suspected Human Carcinogen |
NIOSH DOCUMENTATION AND SURVEILLANCE:
ORGANIZATION
|
STANDARD or SURVEY
|
|
REFERENCE
National Institute for Occupational Safety and Health (NIOSH) Recommended Exposure Level TO DIMETHYLCARBAMOYLCHLORIDE-air
|
Carcinogen lowest feasible conc.
|
NIOSH* DHHS #92-100,1992
|
|
STATUS IN FEDERAL AGENCIES:
ORGANIZATION
|
|
REFERENCE
EPA GENETOX PROGRAM 1988, Positive: Carcinogenicity-mouse/rat; SHE-clonal assay
|
EPA GENETOX PROGRAM 1988, Positive: Host-mediated assay; Mammalian micronucleus
|
EPA GENETOX PROGRAM 1988, Positive: E coli polA without S9; Histidine reversion-Ames test
|
EPA GENETOX PROGRAM 1988, Positive: S cerevisiae-homozygosis
|
EPA GENETOX PROGRAM 1988, Negative: In vitro UDS-human fibroblast
|
EPA TSCA Section 8(b) CHEMICAL INVENTORY
|
Used as a chemical intermediate in the production of drugs and pesticides
|
EPA TSCA Section 8(d) unpublished health/safety studies
|
On EPA IRIS database
|
EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001
|
NIOSH CURRENT INTELLIGENCE BULLETIN 11, 1976
|
NTP 11th Report on Carcinogens,2004:Reasonably anticipated to be a human carcinogen
|
|
REFERENCES:
CODEN
|
|
REFERENCE
BJCAAI
|
British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS,
UK) V.1- 1947-
|
CALEDQ
|
Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick,
Ireland) V.1- 1975-
|
CNJGA8
|
Canadian Journal of Genetics and Cytology. (National Research Council of Canada, Publication
Sales and Distribution, Ottawa ON K1A OR6, Canada) V.1- 1959-
|
DTLVS*
|
The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by
American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996
|
ENMUDM
|
Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see
EMMUEG.
|
IJCNAW
|
International Journal of Cancer. (International Union Against Cancer, 3 rue du Conseil-
General, 1205 Geneva, Switzerland) V.1- 1966-
|
IMEMDT
|
IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications
Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972-
|
JACTDZ
|
Journal of the American College of Toxicology. (Mary Ann Liebert, Inc., 1651 Third Ave., New
York, NY 10128) V.1-12, 1982-1993. Discontinued.
|
JEPTDQ
|
Journal of Environmental Pathology and Toxicology. (Park Forest South, IL) V.1-5(3),
1977-81(?). For publisher information, see JEPOEC.
|
JJIND8
|
JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For
publisher information, see JNCIEQ.
|
JNCIAM
|
Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher
information, see JJIND8.
|
MUREAV
|
Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1-
1964-
|
NDRC**
|
National Defense Research Committee, Office of Scientific Research and Development, Progress
Report.
|
NIOSH*
|
National Institute of Occupational Safety and Health, U.S. Dept. of Health, Education, and
Welfare, Reports and Memoranda.
|
OHSLAM
|
Occupational Health and Safety Letter. (Environews, Inc., 1097 National Press Bldg.,
Washington, DC 20045) V.1- 1970-
|
PAACA3
|
Proceedings of the American Association for Cancer Research. (Waverly Press, 428 E. Preston
St., Baltimore, MD 21202) V.1- 1954-
|
PMRSDJ
|
Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New
York, NY 10017) V.1- 1981-
|
ZAARAM
|
Zentralblatt fuer Arbeitsmedizin und Arbeitsschutz. (Darmstadt, Fed. Rep. Ger.) V.1-25,
1951-75.
|
|